🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Single-arm trial to evaluate the safety and efficacy of ACX-362E \[ibezapol...
Status
Recruiting
Location
UC Davis Medical Center
Start Date
2026-08-06
Trial ID
NCT07513285
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
Clostridium difficile infection (CDI) is one of the most urgent health thre...
Status
Terminated
Location
Boston Medical Center
Start Date
2019-08-23
Trial ID
NCT03795233
Treatments Being Tested
The purpose of this study is to compare the outcome of treatment with nitaz...
Status
Completed
Location
Michael E. DeBakey Veterans Affairs Medical Center
Start Date
2006-01
Trial ID
NCT00304889
Primary objective of this pilot study is to evaluate the effect of recombin...
Status
Unknown
Location
Johns Hopkins Bayview Medical Center
Start Date
2005-10
Trial ID
NCT00377078
Treatments Being Tested
This clinical study is conducted to assess the efficacy of cadazolid compar...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-12
Trial ID
NCT01983683
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of a ...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00127803
Subjects will receive an oral dose of SER-109 in 4 capsules once daily for ...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02437500
Treatments Being Tested
Clostridioides difficile infection (CDI) poses an increasing threat to infa...
Status
Recruiting
Location
Hangzhou First People's Hospital
Start Date
2024-07-01
Trial ID
NCT06788769
Primary objective: To compare the event rate of CDI in groups assigned to A...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00772343